The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) hasn’t been able to follow up on yesterday’s gains and afternoon trade has fallen 0.3% to 5,742 points. Today’s decline is largely down to steep declines in the utilities and materials sectors.
Four shares which have gone against the grain today and jumped higher are listed below. Here’s why they’ve surged higher:
The Bubs Australia Ltd (ASX: BUB) share price is up almost 11% to 10.5 cents after the infant formula and baby food company announced a supply agreement with retail giant Costco. The deal will see Costco offer Bubs infant formula products in its wholesale catalogue nationally and at one of its warehouses in Sydney.
The Capitol Health Ltd (ASX: CAJ) share price has jumped almost 7% to 16 cents despite there being no news out of the diagnostic imaging company. Capitol Health recently raised $38.5 million in order to reduce its debt levels. Management believes the improved balance sheet now provides it with a platform for growth.
The Impedimed Limited (ASX: IPD) share price has followed up on yesterday’s rise with a 3.5% gain to 72.5 cents. Investors have been snapping up the medical device company’s shares after it announced that its first SOZO device had been placed with Scripps Health in the United States. Management is targeting the chronic heart failure market which impacts an estimated 5.7 million people in the country.
The Mesoblast limited (ASX: MSB) share price has also climbed for a second day in a row, this time by 3.5% to $2.01. Yesterday the U.S. Food and Drug Administration granted its MSC-100-IV cell therapy fast-track status. This has the potential to shorten the time to FDA approval. So much so management appears confident that a single successful open-label Phase 3 trial will be sufficient for conditional FDA approval. Whilst this is promising news, I feel it is a little early for an investment.
Our experts here at The Motley Fool Australia have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.
One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…
Another is a diversified conglomerate trading over 40% off it's high, all while offering a fully franked dividend yield over 3%...
Plus 3 more cheap bets that could position you to profit over the next 12 months!
See for yourself now. Simply click here or the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.
Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.